Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy

For patients with recurrent non-small cell lung cancer (NSCLC), treatment options are often limited. Resection may not be feasible due to the location or extent of recurrence and/or patient lung and functional status. Radiotherapy may be appropriate for select patients with recurrent NSCLC, though potential benefits of radiotherapy must be weighed against risks. The use of novel technologies has been used to minimize toxicity risks